Pfizer is looking to fast-track approval for a third booster
dose of its covid-19 vaccine and will request emergency authorization from the U.S.
Food and Drug Administration in August, Pfizer research head Mikael Dolsten said in a
Thursday interview with Bloomberg.
via Gizmodo